Hdt Bio

Developer of immunotherapy for the treatment of cancer & infectious diseases

placeSeattle, Washington, United States calendar_todayFounded 2018 groups32 employees language hdt.bio

Innovation

16 patent families (6 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace accelerating. Cited 3,069 times.

YearFilings
20212
20222
202311
202411
202510
20266

Social engagement

Social engagement: 6.8K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Zoic.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%

Recent activity

22 May 2026
Recognition
Coming soon